276 related articles for article (PubMed ID: 30921980)
21. Linguistic adaptation, validation and comparison of 3 routinely used neuropathic pain questionnaires.
Li J; Feng Y; Han J; Fan B; Wu D; Zhang D; Du D; Li H; Lim J; Wang J; Jin Y; Fu Z
Pain Physician; 2012; 15(2):179-86. PubMed ID: 22430656
[TBL] [Abstract][Full Text] [Related]
22. Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.
Walsh J; Rabey MI; Hall TM
J Manipulative Physiol Ther; 2012; 35(3):196-202. PubMed ID: 22397741
[TBL] [Abstract][Full Text] [Related]
23. Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya.
Garoushi S; Johnson MI; Tashani OA
Libyan J Med; 2017 Dec; 12(1):1384288. PubMed ID: 28971737
[TBL] [Abstract][Full Text] [Related]
24. Validation of a New Arabic Version of the Neuropathic Pain Diagnostic Questionnaire (DN4).
Chatila N; Pereira B; Maarrawi J; Dallel R
Pain Pract; 2017 Jan; 17(1):78-87. PubMed ID: 26895970
[TBL] [Abstract][Full Text] [Related]
25. [The Self -Complete of Leeds Assessment Neuropathic Symptoms and Signs: an attempt to adapt it for Polish population].
Cnotliwy M; Jurewicz A; Gołąb -Janowska M; Kazimierczak A; Głazek W
Pomeranian J Life Sci; 2016; 62(2):18-21. PubMed ID: 29537216
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
Walker SM; Peters J; Verriotis M; Farag F; Jay MA; Howard RF
J Pain; 2024 Feb; 25(2):451-465. PubMed ID: 37741521
[TBL] [Abstract][Full Text] [Related]
27. Measurement Properties of the SF-MPQ-2 Neuropathic Qualities Subscale in Persons with CRPS: Validity, Responsiveness, and Rasch Analysis.
Packham TL; Bean D; Johnson MH; MacDermid JC; Grieve S; McCabe CS; Harden RN
Pain Med; 2019 Apr; 20(4):799-809. PubMed ID: 30346579
[TBL] [Abstract][Full Text] [Related]
28. Development and Persistence of Suspected Neuropathic Pain After Total Knee Arthroplasty in Individuals With Osteoarthritis.
Fitzsimmons M; Carr E; Woodhouse L; Bostick GP
PM R; 2018 Sep; 10(9):903-909. PubMed ID: 29452296
[TBL] [Abstract][Full Text] [Related]
29. [Linguistic adaptation into Spanish and psychometric validation of the ID-Pain questionnaire for the screening of neuropathic pain].
Gálvez R; Pardo A; Cerón JM; Villasante F; Aranguren JL; Saldaña MT; Navarro A; Ruiz MA; Díaz S; Rejas J
Med Clin (Barc); 2008 Nov; 131(15):572-8. PubMed ID: 19080838
[TBL] [Abstract][Full Text] [Related]
30. Validation of the S-LANSS in the community setting.
Weingarten TN; Watson JC; Hooten WM; Wollan PC; Melton LJ; Locketz AJ; Wong GY; Yawn BP
Pain; 2007 Nov; 132(1-2):189-94. PubMed ID: 17869424
[TBL] [Abstract][Full Text] [Related]
31. Neuropathic pain screening questionnaires have limited measurement properties. A systematic review.
Mathieson S; Maher CG; Terwee CB; Folly de Campos T; Lin CW
J Clin Epidemiol; 2015 Aug; 68(8):957-66. PubMed ID: 25895961
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of painDETECT and S-LANSS in identifying the neuropathic component of mixed pain among patients with tumor-related cancer pain.
Higashibata T; Tagami K; Miura T; Okizaki A; Watanabe YS; Matsumoto Y; Morita T; Kinoshita H
Support Care Cancer; 2020 Jan; 28(1):279-285. PubMed ID: 31041583
[TBL] [Abstract][Full Text] [Related]
33. The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study.
Hans G; Masquelier E; De Cock P
BMC Public Health; 2007 Jul; 7():170. PubMed ID: 17650299
[TBL] [Abstract][Full Text] [Related]
34. Can the LANSS scale be used to classify pain in chronic cancer pain trials?
Hardy J; Quinn S; Fazekas B; Agar M; Currow D
Support Care Cancer; 2013 Dec; 21(12):3387-91. PubMed ID: 23934225
[TBL] [Abstract][Full Text] [Related]
35. Validation of the Dutch version of the DN4 diagnostic questionnaire for neuropathic pain.
van Seventer R; Vos C; Giezeman M; Meerding WJ; Arnould B; Regnault A; van Eerd M; Martin C; Huygen F
Pain Pract; 2013 Jun; 13(5):390-8. PubMed ID: 23113981
[TBL] [Abstract][Full Text] [Related]
36. Screening tools for neuropathic pain: can they be of use in individuals with spinal cord injury?
Hallström H; Norrbrink C
Pain; 2011 Apr; 152(4):772-779. PubMed ID: 21272997
[TBL] [Abstract][Full Text] [Related]
37. Neuropathic Pain Screening: Construct Validity in Patients With Sickle Cell Disease.
Powell-Roach K; Yao Y; Ezenwa MO; Schlaeger JM; Suarez ML; Molokie RE; Wang ZJ; Wilkie DJ
West J Nurs Res; 2020 Feb; 42(2):125-130. PubMed ID: 30900520
[TBL] [Abstract][Full Text] [Related]
38. Development and preliminary validation of the NePIQoL: a quality-of-life measure for neuropathic pain.
Poole HM; Murphy P; Nurmikko TJ
J Pain Symptom Manage; 2009 Feb; 37(2):233-45. PubMed ID: 18676118
[TBL] [Abstract][Full Text] [Related]
39. Validation of the Nepali Version of the Self-reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) in Adults With Chronic Pain and Predominantly Low-literacy Levels.
Sharma S; Higgins C; Cameron P; Bimali I; Hales TG; Bennett MI; Colvin L; Smith BH
J Pain; 2022 Mar; 23(3):424-433. PubMed ID: 34583020
[TBL] [Abstract][Full Text] [Related]
40. Acute and chronic neuropathic pain in the hospital setting: use of screening tools.
Sadler A; Wilson J; Colvin L
Clin J Pain; 2013 Jun; 29(6):507-11. PubMed ID: 23247003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
